ENGLEWOOD, Colo., Sept. 3, 2024 /PRNewswire/ -- Zynex Inc. (NASDAQ: ZYXI), a leading medical technology company specializing in non-invasive medical devices for pain management and rehabilitation, ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. TriCare, the federal health ...
Zynex, a medical device manufacturer, has reported a 36% year-over-year increase in revenue in Q1 2023, reaching $42.2 million, with a 14% increase in net income. Despite short-term underperformance, ...
Throughout the last three months, 4 analysts have evaluated Zynex (NASDAQ:ZYXI), offering a diverse set of opinions from bullish to bearish. The table below provides a concise overview of recent ...
Zynex missed on second-quarter revenue and earnings, and guided down. However, some of the near-term weakness was by design, as the company is cutting costs. The stock looks very cheap if the company ...
ENGLEWOOD, Colo., Nov. 13, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...
* Depreciation does not include amounts related to units on lease to third parties which are depreciated and included in cost of goods sold. ** Severance of former corporate employees which were fully ...
SAN FRANCISCO, March 28, 2025 (GLOBE NEWSWIRE) -- A securities class action has been filed against Zynex, Inc. (NASDAQ: ZYXI), a medical device manufacturer that produces and markets electrotherapy ...
TipRanks on MSN
Zynex Expands Board, Appoints New Director
Zynex ( ($ZYXI) ) has shared an update. On October 7, 2025, Zynex, Inc. expanded its Board of Directors from five to six members by appointing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback